Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1977 3
1978 6
1979 3
1980 7
1981 3
1982 12
1983 5
1984 9
1985 6
1986 5
1987 4
1988 8
1989 10
1990 5
1991 2
1992 5
1993 7
1994 8
1995 6
1996 8
1997 10
1998 4
1999 3
2000 5
2001 10
2002 6
2003 6
2004 10
2005 12
2006 10
2007 11
2008 9
2009 13
2010 10
2011 10
2012 9
2013 11
2014 9
2015 7
2016 10
2017 5
2018 6
2019 10
2020 7
2021 6
2022 10
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

351 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1).
Fedgchin M, Trivedi M, Daly EJ, Melkote R, Lane R, Lim P, Vitagliano D, Blier P, Fava M, Liebowitz M, Ravindran A, Gaillard R, Ameele HVD, Preskorn S, Manji H, Hough D, Drevets WC, Singh JB. Fedgchin M, et al. Among authors: preskorn s. Int J Neuropsychopharmacol. 2019 Oct 1;22(10):616-630. doi: 10.1093/ijnp/pyz039. Int J Neuropsychopharmacol. 2019. PMID: 31290965 Free PMC article. Clinical Trial.
Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial.
Citrome L, Preskorn SH, Lauriello J, Krystal JH, Kakar R, Finman J, De Vivo M, Yocca FD, Risinger R, Rajachandran L. Citrome L, et al. Among authors: preskorn sh. J Clin Psychiatry. 2022 Oct 3;83(6):22m14447. doi: 10.4088/JCP.22m14447. J Clin Psychiatry. 2022. PMID: 36198061 Free article. Clinical Trial.
Tardive Dyskinesia: A Historical Perspective.
Macaluso M, Flynn A, Preskorn SH. Macaluso M, et al. Among authors: preskorn sh. J Psychiatr Pract. 2017 Mar;23(2):121-129. doi: 10.1097/PRA.0000000000000224. J Psychiatr Pract. 2017. PMID: 28291037 Review.
Duloxetine.
Preskorn SH. Preskorn SH. J Psychiatr Pract. 2004 Nov;10(6):375-85. doi: 10.1097/00131746-200411000-00006. J Psychiatr Pract. 2004. PMID: 15583519 Review. No abstract available.
Lurasidone drug-drug interaction studies: a comprehensive review.
Chiu YY, Ereshefsky L, Preskorn SH, Poola N, Loebel A. Chiu YY, et al. Among authors: preskorn sh. Drug Metabol Drug Interact. 2014;29(3):191-202. doi: 10.1515/dmdi-2014-0005. Drug Metabol Drug Interact. 2014. PMID: 24825095 Free article. Review.
Reverse Engineering Drugs: Lorcaserin as an Example.
Schwasinger-Schmidt T, Preskorn SH. Schwasinger-Schmidt T, et al. Among authors: preskorn sh. Adv Neurobiol. 2023;30:195-206. doi: 10.1007/978-3-031-21054-9_8. Adv Neurobiol. 2023. PMID: 36928851
Dr Preskorn replies.
Preskorn SH. Preskorn SH. J Clin Psychiatry. 2013 Oct;74(10):1025-6. doi: 10.4088/JCP.13flr08555a. J Clin Psychiatry. 2013. PMID: 24229758 No abstract available.
351 results